Stemetil 5mg Tablet MD

Medically reviewed by Dr. Nilanjan Chandra | Written By Kunal V Kumar

Last updated on: November 02, 2020 2:53 am

Stemetil 5mg Tablet MD

Read this article in: हिन्दी

Uses of Stemetil 5mg Tablet MD

Stemetil 5mg Tablet MD is used for the treatment or prevention of the following disease(s):

Nausea, Vomiting , Schizophrenia, Anxiety

Side effects of Stemetil 5mg Tablet MD

The most common side effects of Stemetil 5mg Tablet MD are – Blurred Vision, Dry Mouth, Nasal Congestion, Ocular Changes, Constipation, Epigastric Pain, Nausea, Vomiting

These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.

Precautions while using Stemetil 5mg Tablet MD

Do not use Stemetil 5mg Tablet MD if you are allergic to – Prochlorperazine

If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Stemetil 5mg Tablet MD.

If you are allergic to any medicine or food, consult your doctor before using this medicine.

Use this medicine under the supervision of your doctor.

To avoid an adverse reaction, consult your doctor if you are already taking other medicines.

How Stemetil 5mg Tablet MD works

Stemetil 5mg Tablet MD contains – Prochlorperazine

Prochlorperazine is thought to work by blocking the action of a chemical called dopamine which acts on the nervous system in the brain.

Dosage of Stemetil 5mg Tablet MD

The dosage of Stemetil 5mg Tablet MD depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.

Please use this medicine as prescribed by your doctor.

Overdose of Stemetil 5mg Tablet MD

If you forget to take a dose of Stemetil 5mg Tablet MD, do not take two doses at the same time, there is a risk of overdose.

If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.

Precautions & Warnings

Alcohol

Information will be added soon.

Pregnancy

Information will be added soon.

Breastfeeding

Information will be added soon.

Driving

Information will be added soon.

Kidney

Information will be added soon.

Liver

Information will be added soon.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.

Emikind 5mg Tablet MD  ( Mankind Pharma Ltd. )

33.27  10 Tablets Strip Tablets Strip

Stemil 5mg Tablet  ( Theo Pharma Pvt. Ltd. )

28.00  10 Tablets Strip Tablets Strip

Resvom 5mg Tablet MD  ( Unimarck Healthcare Ltd. )

40.00  10 Tablets Strip Tablets Strip

Vometil 5mg Tablet  ( Cipla Ltd. )

14.00  10 Tablets Strip Tablets Strip

Stimat 5mg Tablet  ( Zydus Cadila )

16.00  10 Tablets Strip Tablets Strip

Interaction

Drug :- aluminum- or magnesium-containing antacids, antidiarrheals adsorbent: Possibly inhibited absorption of oral prochlorperazine amantadine, anticholinergics, antidyskinetics, antihistamines: Possibly intensified anticholinergic adverse effects, increased risk of prochlorperazine-induced hyperpyretic effect.

amphetamines: Decreased stimulant effect of amphetamines, decreased antipsychotic effect of prochlorperazine.

anticonvulsants: Lowered seizure threshold.

antithyroid drugs: Increased risk of agranulocytosis.

apomorphine: Possibly decreased emetic response to apomorphine, additive CNS depression.

appetite suppressants: Possibly antagonized anorectic effect of appetite suppressants.except for phenmetrazine.

astemizole, cisapride, disopyramide, erythromycin, pimozide, probucol, procainamide: Additive QT interval prolongation, increased risk of ventricular tachycardia.

beta blockers: Increased risk of additive hypotensive effects, irreversible retinopathy, arrhythmias, and tardive dyskinesia.

bromocriptine: Decreased effectiveness of bromocriptine.

CNS depressants: Additive CNS depression.

dopamine: Possibly antagonized peripheral vasoconstriction high doses of dopamine.

ephedrine, epinephrine: Decreased vasopressor effects of these drugs.

hepatotoxic drugs: Increased risk of hepatotoxicity.

hypotension-producing drugs: Possibly severe hypotension with syncope.

levodopa: Inhibited antidyskinetic effect of levodopa.

lithium: Reduced absorption of oral prochlorperazine, increased lithium excretion, increased extrapyramidal effects, possibly masking of early symptoms of lithium toxicity. MAO inhibitors, maprotiline, tricyclic antidepressants: Possibly prolonged and intensified anticholinergic and sedative effects, increased antidepressant level, inhibited prochlorperazine metabolism, increased risk of neuroleptic malignant syndrome.

mephentermine: Possibly antagonized antipsychotic effect of prochlorperazine and vasopressor effect of mephentermine.

metrizamide: Increased risk of seizures.

opioid analgesics: Increased risk of CNS and respiratory depression, orthostatic hypotension, severe constipation, urine retention.

ototoxic drugs: Possibly masking of some symptoms of ototoxicity, such as dizziness, tinnitus, and vertigo.

phenytoin: Possibly inhibited phenytoin.

metabolism, increased risk of phenytoin toxicity.

thiazide diuretics: Possibly potentiated hyponatremia and water intoxication.

Activity :- alcohol use: Additive CNS depression.

About Reviewer

Dr. Nilanjan Chandra is a talented Psychiatrist, Psychotherapist, De-addiction specialist, and Sex Therapist with 10 years of experience. He's currently practicing as a Consultant Neuro-psychiatrist at Institute of Neurosciences, Kolkata. He completed his MBBS from Calcutta National Medical College in 2011 and MD from Government Medical College and New Civil Hospital, Surat in 2016.

About Author

Kunal is a registered pharmacist with RGUHS with over 11 months experience. He is a medicine content contributor at Zotezo.

ZOTEZO IN THE NEWS

...